JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where ...

JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...

JMP Securities increased their price target on Blue Owl Capital Corp. (NYSE: OBDC) shares, boosting it to $17.00 from the previous target of $16.50. The firm maintained its Market Outperform rating on ...

Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report)‘s stock had its “market perform” rating reissued by stock analysts at JMP Securities in a research report issued on Monday,Benzinga reports.

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

Investing.com -- JMP Securities initiated coverage on digital infrastructure companies on AI related spending boom. Over the next five years, over $1 trillion in investments is expected ...

Meta Platforms, Inc (NASDAQ:META) stock is trading higher after multiple firms raised their price forecasts on the stock ...

Fintel reports that on January 31, 2025, JMP Securities initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Market Outperform recommendation. As of January 29, 2025, the average one ...

On Friday, JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a price target of $26.00. The stock, currently trading at $7.49, ...